James Webb

James Webb has a diverse and extensive work experience. James currently serves as the Chief Commercial Officer (CCO) at Epidisease SL since October 2022. Prior to this, James worked as a Freelance Consultant and Writer, where they developed funding proposals, provided strategic guidance for biotechnology portfolios, and developed scale-up strategies for complex markets.

In 2019, James worked as a Mentor at IE Business School, where they shared their expertise with students. James also held roles at Vygon España during this period, serving as the Business Unit Manager for Intensive Care and Anesthesia & Emergency. In these positions, they developed and executed marketing and business development plans, achieved commercial objectives, and led teams.

Before that, James co-founded JVVL in 2017, an international consultancy group focusing on ICT solutions for healthcare and wellness. James was responsible for planning and implementing sales, marketing, and business development strategies. James also worked as an evaluator, mentor, and business coach for Horizon 2020 EU eHealth, collaborating with innovation clusters and providing expertise in healthcare, eHealth, and mHealth.

From 2016 to 2018, James held the position of Chief Commercial & Operations Officer at Neuron Biolabs, where they oversaw commercial operations, business development, market access, and investor relations. Prior to this, they served as an Assistant Country Manager at BioMarin Pharmaceutical Inc., leading marketing, sales, and access functions for orphan biotechnology treatments.

James also has experience working at Biomet, where they were the Rapid Recovery National Product Manager, driving the launch and business generation for their innovative system. James started their career at Biogen as the Tysabri Sales Manager, ensuring the successful launch of a therapy and maximizing territory sales and profits.

Throughout their career, James has demonstrated expertise in commercial strategy, business development, marketing, sales, and market access in the pharmaceutical and biotechnology sectors.

James Webb's education history is as follows:

In 1990, they began their undergraduate studies at Heriot-Watt University, where they pursued a Bachelor of Science (BSc) degree in Biochemistry and Molecular Biology. James completed this program in 1995.

During the same year, Webb also enrolled in the University of Southampton for a Master of Philosophy (MPhil) degree in Molecular Genetics, which they successfully obtained in 2000. Additionally, from 1995 to 1996, they attended the University of Leicester and earned a Master of Science (MSc) degree in Molecular Genetics.

In pursuit of further academic excellence, Webb joined the University of Southampton once again in 1995, this time for a Doctor of Philosophy (PhD) program in Molecular Genetics. The exact end year for this program is not provided.

Later, in 2014, Webb attended the IE Business School, where they completed an Executive MBA+ degree in Entrepreneurship/Entrepreneurial Studies in 2015.

Apart from their formal education, Webb obtained additional certifications as well. In February 2021, they completed the "Prescription Drug Regulation, Cost, and Access: Current Controversies in Context" course from HarvardX. In May 2020, they also completed the "Lessons from Ebola: Preventing the Next Pandemic" course offered by Harvard University.

Lastly, Webb holds a certification from the Chartered Institute of Marketing (CIM), but the specific completion month and year are not provided.